Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease

Hormone Research

Volumn 66, Issue 1, 2006, Pages 21-26

  Beltran, S ^a   Lescure, F X ^a   El Esper, I ^a   Schmit, J L ^a   Desailloud, R ^a,b  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Antiretrovirals; Dialysis equilibrium; Highly active anti retroviral therapy; HIV infection; Hypothyroidism

Indexed keywords

3,3',5' TRIIODOTHYRONINE; GAMMA INTERFERON; IODINE; LIOTHYRONINE; PROTIRELIN; SELENIUM; THIOCYANATE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HIV INFECTIONS; HUMANS; HYPOGONADISM; HYPOTHYROIDISM; INTERFERON TYPE II; IODINE; MIDDLE AGED; PROSPECTIVE STUDIES; THYROID GLAND; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; THYROXINE; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 33745444310     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093228     Document Type: Article

References (34)

1. Collazos J, Ibarra S, Mayo J: Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: evidence of an interrelation between the thyroid axis and the immune system. AIDS 2003;17:763-765.
2. Grappin M, Piroth L, Verges B, Sgro C, Mack G, Buisson M, Duong M, Chavanet P, Portier H: Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS 2000;14:1070-1072.
3. Calza L, Manfredi R, Chiodo F: Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002;31:361-368.
4. Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, Arlot S, Schmit JL; Thyroid and VIH Group: Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening. Clin Infect Dis 2003;37:579-583.
5. Panamonta O, Kosalaraksa P, Thinkhamrop Bkirdpon W, Ingchanin C, Lumbiganon P: Endocrine function in Thai children infected with human immunodeficiency virus. J Pediatr Endocrinol Metab 2004;17:33-40.
6. Vigano A, Riboni S, Bianchi R, Cafarelli L, Vago T, Manzoni P, Di Natale B: Thyroid dysfunction in antiretroviral treated children. Pediatr Infect Dis J 2004;23:235-239.
7. Quirino T, Bongiovanni M, Ricci E, Chebat E, Carradori S, Martinelli C, Valsecchi L, Landonio S, Bini T, Bonfanti P; Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group: Hypothyroidism in HIV-infected patients who have or have not received HAART. Clin Infect Dis 2004;38:596-597.
8. Centers for Disease Control and Prevention: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
9. Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ: Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997;82:771-776.
10. Spencer CA, Takeuchi M, Kazarobsyan M: Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996;42:140-145.
11. Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P: Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 2000;85:3631-3635.
12. Alexopoulou O, Beguin C, De Nayer P, Maiter D: Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 2004;150:1-8.
13. Stevenson HP, Archbold GP, Johnston P, Young IS, Sheridan B: Misleading serum free thyroxine results during low molecular weight heparin treatment. Clin Chem 1998;44:102-107.
14. Chopra IJ: Simultaneous measurement of free thyroxine and free 3,5,3′-triiodothyronine undiluted serum by direct equilibrium dialysis/radioimmunoassay: evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome. Thyroid 1998;8:249-257.
15. Sakata S, Nakamura S, Miura: Autoantibodies against thyroid hormones or iodothyronine. Ann Intern Med 1985;103:579-589.
16. Stockigt JR: Free thyroid hormone measurement. A critical appraisal. Endocrinol Metab Clin North Am 2001;30:265-289.
17. De Groot L: Dangerous dogmas in Medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999;84:151-164.
18. Duntas L, Nguyen T, Keck F, Nelson DK, Iii JJ: Changes in metabolism of TRH in euthyroid sick syndrome. Eur J Endocrinol 1999;141:337-341.
19. Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V: Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNF-alpha in non thyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab 2001;86:4198-4205.
20. Merenich J, Mc Dermott T, Asp A, Harrison SM, Kidd GS: Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab 1990;70:566-571.
21. Fontes R, Vangeloti A, Pires ML, Lima MB, Dimetz T, Faulhaber M, Faria R Jr, Meirelles RM: Endocrine disorders in Brazilian patients with acquired immune deficiency syndrome. Clin Infect Dis 2003;37:S137-S141.
22. Walker UA: Update on mitochondrial toxicity: where are we now? J HIV Ther 2003;8:32-35.
23. Landriscina M, Fabiano A, Altamura S, Bagala C, Piscazzi A, Cassano A, Spadafora C, Giorgino F,Barone C, Cignarelli M: Reverse transcriptase inhibitors downregulate cell proliferation in vitro and in vivo and restore TSH signaling and iodine uptake in human thyroid anaplastic carcinoma. J Clin Endocrinol Metab 2005;90:5663-5671.
24. Zandman-Goddard G, Shoenfeld Y: HIV and autoimmunity. Autoimmun Rev 2002;1:329-337.
25. Chen F, Day SL, Metcalfe RA, Sethi G, Kapembwa MS, Brook MG, Churchill D, de Ruiter A, Robinson S, Lacey CJ, Weetman AP: Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) 2005;84:98-106.
26. Levacher M, Bouscarat F, Landman R, Chau F, Damond F, Gaudebout C, Mathez D, Leibowitch J, Saimot AG, Sinet M: Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine and ritonavir. Res Hum Retroviruses 2000;16:1869-1875.
27. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M: Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation 2004;11:209-213.
28. Zimmermann M, Köhrle J: The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002;12:867-878.
29. Rayman P: The importance of selenium to human health. Lancet 2000;356:233-241.
30. Erdogan MF: Thiocyanate overload and thyroid disease. Biofactors 2003;19:107-111.
31. Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P: Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 2000;85:3631-3635.
32. Faglia G: The clinical impact of the thyrotropin-releasing hormone test. Thyroid 1998;8:903-908.
33. Wang R, Nelson JC, Wilcox RB: Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyrin, and albumin. Thyroid 1999;9:359-364.
34. Okabayashi T, Takeda K, Kawada M, Kubo Y, Nakamura S, Chikamori K, Terao N, Hashimoto K: Free thyroxine concentrations in serum measured by equilibrium dialysis in chronic renal failure. Clin Chem 1996;42:1616-1620.